Biotech firm Rubius Therapeutics gains state incentives, will open new plant

By
-
RUBIUS THERAPEUTICS was approved for a potential $9 million in tax incentives by the R.I. Commerce Corp. Thursday. The company plans to retrofit a Smithfield manufacturing facility through a $155 million investment.
RUBIUS THERAPEUTICS was approved for a potential $9 million in tax incentives by the R.I. Commerce Corp. Thursday. The company plans to retrofit a Smithfield manufacturing facility through a $155 million investment.
PROVIDENCE – R.I. Commerce Corp., the state’s economic development agency, on Thursday approved a package of tax reductions and incentives potentially worth more than $9 million for Rubius Therapeutics Inc. to open a pharmaceutical manufacturing plant in Smithfield. In return, the Cambridge, Mass.-based biotechnology company has pledged to create 160 jobs at the site with…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -

RELATED ARTICLESMORE FROM AUTHOR